This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Johns Hopkins University, Lieber Institute, Inc.. Active years: 2025-2026.
Company Filing History:
2 out of 3,790 
1 out of 9 
Years Active: 2025-2026
Title: Hester Hui Liu: Innovator in Cancer Treatment Strategies
Introduction
Hester Hui Liu is a prominent inventor based in Cockeysville, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research and patent developments. Liu's work focuses on combinatory treatment strategies that target cancer through RNA polymerase I inhibition.
Latest Patents
Hester Hui Liu holds a patent for her invention titled "Combinatory treatment strategies of cancer based on RNA polymerase I inhibition." This patent discloses compositions that comprise a combination of at least one Pol I inhibitor, along with at least one autophagy inhibiting compound, and/or at least one ACAT1 inhibiting compound, and/or at least one PARP inhibiting compound. These compositions are designed for use in treating cancers and other related neoplastic diseases, potentially including additional chemotherapeutic agents. Liu's innovative approach aims to enhance the effectiveness of cancer treatments.
Career Highlights
Liu is affiliated with The Johns Hopkins University, where she continues her research and development in cancer therapies. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from various forms of cancer. With her dedication to advancing medical science, Liu has established herself as a key figure in the field of oncology research.
Collaborations
Liu collaborates with esteemed colleagues, including Marikki Laiho and Paul Sirajuddin. These partnerships enhance her research efforts and contribute to the development of effective cancer treatment strategies.
Conclusion
Hester Hui Liu's innovative work in cancer treatment exemplifies the impact of research and invention in the medical field. Her contributions through her patent and collaborations highlight the importance of continued innovation in combating cancer. Liu's dedication to improving patient outcomes through her research is commendable and reflects the ongoing efforts of inventors in the healthcare sector.